A Phase 1 Study of the Safety and Pharmacokinetics of GC4711 (Oral Capsule) Compared to GC4419 (IV Infusion) and GC4711 (IV Infusion) in Healthy Volunteers

NCT03099824 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
56
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Galera Therapeutics, Inc.